Literature DB >> 11714446

Increased apoptosis associated with depressed type of early intestinal gastric cancer.

M Masutani1, J Suzuki, T Matsuda, A Dochin, K Sadaoka, A Nomura, K Ohira, K Takahashi, K Yamazaki, H Dosaka-Akita, M Nishimura, Y Kawakami.   

Abstract

Early gastric cancer can be macroscopically classified into elevated and depressed types. To clarify the relationship between macroscopic appearance of early gastric cancer and apoptosis or cell proliferation, formalin-fixed paraffin-embedded tissue specimens of 44 intestinal-type early gastric cancers were investigated by the TUNEL method and immunohistochemical techniques. Diffuse type was excluded in this study. When tissue sections of gastric cancer were vertically classified into the 3 compartments of luminar, intermediate and basal, the apoptosis index (%) was significantly higher in the basal compartment of depressed type (1.76 +/- 2.04, mean +/- SD) than in the basal compartment of elevated type (0.63 +/- 0.81, P = 0.01). In depressed type, the apoptosis index (%) was significantly higher in the basal compartment than in the luminar compartment (0.76 +/- 0.85, P = 0.03). Apoptosis-inducing protein, Bax, was expressed more in each of the compartments of depressed type than in those of elevated type, while there were no significant differences in expression of anti-apoptotic protein, Bcl-2, between the two types. Moreover, the apoptosis index (%) of Bax-positive gastric cancer was significantly higher in the basal compartment (P = 0.03), compared to that of Bax-negative gastric cancer, while there were no significant differences in apoptosis index (%) in any compartment between Bcl-2-positive and Bcl-2-negative gastric cancers. There were no significant differences in Ki-67 expression, either between the two types, or among the compartments of depressed type. These results indicate that increased apoptosis with excessive expression of Bax in the basal compartment is involved in the morphogenesis of the depressed type in intestinal-type early gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11714446      PMCID: PMC5926658          DOI: 10.1111/j.1349-7006.2001.tb02142.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  36 in total

1.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

2.  BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.

Authors:  D M Hockenbery; M Zutter; W Hickey; M Nahm; S J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

3.  Endoscopic mucosal resection for treatment of early gastric cancer.

Authors:  H Ono; H Kondo; T Gotoda; K Shirao; H Yamaguchi; D Saito; K Hosokawa; T Shimoda; S Yoshida
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

4.  Early cancer of the stomach.

Authors:  T Murakami
Journal:  World J Surg       Date:  1979-11       Impact factor: 3.352

5.  Differential expression of apoptosis receptors on diffuse and intestinal type stomach carcinoma.

Authors:  H P Vollmers; J Dämmrich; F Hensel; H Ribbert; A Meyer-Bahlburg; T Ufken-Gaul; M von Korff; H K Müller-Hermelink
Journal:  Cancer       Date:  1997-02-01       Impact factor: 6.860

6.  Inward growth of colonic adenomatous polyps.

Authors:  S F Moss; T C Liu; A Petrotos; T M Hsu; L I Gold; P R Holt
Journal:  Gastroenterology       Date:  1996-12       Impact factor: 22.682

7.  Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2.

Authors:  S Krajewski; M Krajewska; A Shabaik; T Miyashita; H G Wang; J C Reed
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

8.  Molecular mechanism of stomach carcinogenesis.

Authors:  E Tahara
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

9.  Increased apoptosis accompanies neoplastic development in the human colorectum.

Authors:  F A Sinicrope; G Roddey; T J McDonnell; Y Shen; K R Cleary; L C Stephens
Journal:  Clin Cancer Res       Date:  1996-12       Impact factor: 12.531

10.  Apoptosis, cell proliferation and expression of Bcl-2 and Bax in gastric carcinomas: immunohistochemical and clinicopathological study.

Authors:  Y Koshida; M Saegusa; I Okayasu
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more
  2 in total

1.  Depressed type of intramucosal differentiated-type gastric cancer has high cell proliferation and reduced apoptosis compared with the elevated type.

Authors:  Toshihiko Nakamura; Takashi Yao; Yoshihiro Kakeji; Hideaki Anai; Masaru Morita; Yoshinao Oda; Yoshihiko Maehara
Journal:  Gastric Cancer       Date:  2012-04-18       Impact factor: 7.370

2.  Therapeutic mechanism of ginkgo biloba exocarp polysaccharides on gastric cancer.

Authors:  Ai-Hua Xu; Hua-Sheng Chen; Bu-Chan Sun; Xiao-Ren Xiang; Yun-Fei Chu; Fan Zhai; Ling-Chang Jia
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.